Educational content only. This post explains how equity injection concepts apply generally to Canadian healthcare practice lending. Specific lender requirements vary considerably. Consult a commercial lender or loan broker before making decisions about equity contribution levels.
When you apply for a commercial loan to open or acquire a healthcare practice in Canada, the lender will want to know how much of your own money you're putting in. This is your equity injection — the cash contribution you make against the project. It is one of the first things a lender evaluates, and it has more influence on your loan terms than most first-time borrowers realize.
This post covers what Canadian lenders typically want, what actually counts as equity injection, and why injecting more than the minimum often produces materially better outcomes.
What Lenders Want to See
Published Canadian commercial lending sources consistently describe equity injection in the range of 20–35% of total project cost as the preferred zone for healthcare practice loans. Some lenders will accept less in specific circumstances, particularly for borrowers with strong personal credit and proven practice ownership history. Others expect more, particularly for startup scenarios or specialty practices considered higher risk.
The Canada Small Business Financing Program (CSBFP) has its own structure. CSBFP loans for equipment can finance up to 90% of equipment cost, meaning the equity injection on the equipment portion can be as low as 10%. CSBFP for real estate similarly allows higher leverage on qualifying property. But CSBFP is one component of most healthcare practice deals, not the entire deal — and the non-CSBFP portion typically falls back to standard commercial lender expectations on equity.
BDC, the Business Development Bank of Canada, has healthcare-specific lending programs and tends to be flexible on equity injection in some scenarios, particularly for borrowers with strong projections and clear business plans. Conventional chartered bank lending typically holds closer to the 25–35% range for new healthcare practice deals.
Why the Percentage Matters
Equity injection does three things from a lender's perspective.
It reduces the loan amount, which directly improves the lender's risk position. A 30% equity injection on a $700,000 project means the lender is financing $490,000 against a $700,000 asset base. A 15% injection means financing $595,000 against the same base. The lender's exposure if something goes wrong is materially different.
It demonstrates borrower commitment. A borrower contributing meaningful personal capital has skin in the game. A borrower contributing minimum equity has less to lose if the deal goes sideways, and lenders price that risk into the loan terms.
It improves the practice's debt service coverage from day one. Lower loan amount means lower monthly debt service, which means higher DSCR for the same level of operating cash flow. Many borderline deals become approvable simply by increasing the equity contribution.
The Difference Between Minimum and Preferred
Hitting the minimum gets you approved. Going above the minimum often changes the terms.
A borrower bringing 35% equity to a deal frequently gets a better rate, longer amortization, lighter covenants, or a personal guarantee with reduced scope. A borrower at 20% gets approved on standard terms with no leverage to negotiate.
Worth thinking about as a financial decision: if you have 35% equity available but contribute 25%, you're keeping 10% of project cost on your personal balance sheet earning whatever interest your bank pays. The 10% you didn't contribute is replaced by 10% of additional debt at commercial rates. The math frequently favours contributing the additional equity, particularly if the savings on rate or term are meaningful.
That said, working capital matters too. Contributing every available dollar to the project at closing leaves nothing for the ramp period. The right answer is rarely "maximum equity" or "minimum equity." It's usually finding the level that produces good loan terms while preserving an adequate working capital reserve for the first 12 to 18 months.
What Counts as Equity Injection
Most Canadian lenders accept several sources as equity contribution.
Personal cash savings. The simplest case — money in your bank account contributed at closing.
Family or related-party loans. Parents, siblings, or other family members lending you money against the project. Lenders typically want documentation of the loan terms and may require subordination — meaning the family loan sits behind the commercial loan in priority. Some lenders treat family loans as equity for injection purposes; others count them as additional debt that affects DSCR.
Home equity line of credit. Drawing on home equity to fund the practice contribution is common. The lender treats the funds as equity injection but is aware that you're carrying the HELOC debt personally.
RRSP or registered account contributions. In Canada, drawing from RRSPs to fund a business has tax implications and is rarely recommended without specific accountant guidance. Some structures use a small business investment held within an RRSP, but these are specialized and require careful structuring.
Seller financing in acquisition deals. When buying an existing practice, the seller may hold a portion of the purchase price as a note. In some structures and with some lenders, a portion of the seller note can count toward equity injection requirements. This varies by lender and deal structure.
What Doesn't Count
A few sources of capital don't typically qualify as equity injection.
Borrowed funds being represented as cash. A line of credit drawn the day before closing and represented to the lender as cash savings is generally not acceptable. Most lenders require equity to be seasoned — meaning the funds have been in your account for a defined period before closing, often 60 to 90 days.
Other commercial debt against the project. Borrowing from one lender to fund the equity contribution to another lender's loan is generally prohibited and surfaces in due diligence.
Anticipated income. Future revenue, projected practice earnings, or expected family gifts that haven't actually arrived don't count. Lenders need to see the equity at closing.
Equity Injection in Acquisition Deals
Practice acquisitions in Canada often have different equity dynamics than startups.
Acquisition deals typically have lower required equity injections in percentage terms because the practice has demonstrated cash flow that supports the financing. A practice with three years of stable revenue history is a different risk than a startup with projected revenue. Lenders often accept 15–25% equity on healthy acquisition deals, with the remainder financed through commercial debt and sometimes seller financing.
The structural mechanics also differ. Acquisitions involve goodwill, which is harder to finance than tangible assets. A deal where the seller is willing to hold a 10–15% note often produces better lender outcomes than an all-cash deal at the same total price.
Building Your Equity Position
If you're planning a practice purchase or startup 12 to 24 months in the future, the equity injection question is something to plan for early.
Most operators planning healthcare practice ownership end up funding equity through some combination of personal savings accumulated during associate or employed practice years, family contributions, and home equity. The specific mix varies. What's consistent is that the borrowers who arrive at the lender with 30–35% equity in cash get materially better deals than those scrambling to assemble 15% from various sources at the last minute.
This is one of the financial planning conversations worth having with your accountant well before you start looking at specific opportunities.
Then use the Capital Structure Tool to model loan scenarios at different loan amounts. Running the tool with the loan amount that corresponds to 15%, 25%, or 35% equity contribution lets you compare the monthly obligation and total cost under each scenario.
Disclaimer: Equity injection ranges and lender practices described are drawn from published commercial lending sources and represent general patterns. Specific lender requirements depend on borrower profile, deal structure, market conditions, and many factors. KlinDeck is not a lender, broker, accountant, or financial advisor. Content is educational only. Consult qualified professionals before making financing decisions.